Brief: argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG
08/05/2026 22:27
May 8 (Reuters) - argenx SE ARGX.BR: ARGENX ANNOUNCES U.S. FDA APPROVAL EXPANDING VYVGART AND VYVGART HYTRULO FOR USE IN ALL ADULT PATIENTS LIVING WITH GMG Source text: ID:nGNXb77Rxb Further company coverage: ARGX.BR ((Reuters.Briefs@thomsonreuters.com;))